Literature DB >> 29302898

Systemic Non-Hodgkin T Cell Lymphomas Presenting in the Head and Neck Region: An Institutional Experience of a Rare Entity.

Devin R Broadwater1, Deniz Peker2.   

Abstract

T cell lymphoma (TCL) is a group of rare and aggressive diseases. TCL primary to head and neck organs often present as extranodal NK/T cell lymphoma, nasal type. Systemic TCL with initial head and neck presentation is extremely rare. Here we report our institutional experience. Clinicopathologic data was collected from patients diagnosed with TCL and treated at the University of Alabama at Birmingham between 2002 and 2012. Eleven cases of systemic TCL initially presented at head and neck region were identified. The median age was 54 years and male:female ratio was 1.8. The most common sites involved were sinonasal tissue, tonsil, tongue and larynx. Most patients presented with a mass lesion without systemic symptoms. The presentation of TCL primary to the head and neck region is often non-specific. A misdiagnosis of undifferentiated tumor or chronic inflammation due to ambiguous morphology is not uncommon. TCL should be considered in differential diagnosis and a thorough evaluation is warranted for accurate diagnosis.

Entities:  

Keywords:  Head and neck; Lymphoma; Non-Hodgkin; T Cell

Mesh:

Year:  2018        PMID: 29302898      PMCID: PMC6232224          DOI: 10.1007/s12105-017-0881-3

Source DB:  PubMed          Journal:  Head Neck Pathol        ISSN: 1936-055X


  10 in total

Review 1.  Primary extranodal non-Hodgkin's lymphomas. Part 2: Head and neck, central nervous system and other less common sites.

Authors:  E Zucca; E Roggero; F Bertoni; A Conconi; F Cavalli
Journal:  Ann Oncol       Date:  1999-09       Impact factor: 32.976

Review 2.  Primary extranodal non-Hodgkin's lymphomas. Part 1: Gastrointestinal, cutaneous and genitourinary lymphomas.

Authors:  E Zucca; E Roggero; F Bertoni; F Cavalli
Journal:  Ann Oncol       Date:  1997-08       Impact factor: 32.976

3.  Changing incidence of oral and maxillofacial tumours in East Java, Indonesia, 1987-1992. Part 2: Malignant tumours.

Authors:  T I Budhy; S D Soenarto; H B Yaacob; W C Ngeow
Journal:  Br J Oral Maxillofac Surg       Date:  2001-12       Impact factor: 1.651

4.  Epidemiology of Nasopharyngeal Lymphoma in the United States: A Population-Based Analysis of 1119 Cases.

Authors:  Albert Y Han; Edward C Kuan; Jose E Alonso; Karam W Badran; Maie A St John
Journal:  Otolaryngol Head Neck Surg       Date:  2017-03-21       Impact factor: 3.497

5.  Clinical and prognostic differences between ALK-negative anaplastic large cell lymphoma and peripheral T cell lymphoma, not otherwise specified: a single institution experience.

Authors:  Xiu-Wen Deng; Xi-Mei Zhang; Wei-Hu Wang; Shu-Lian Wang; Jing Jin; Hui Fang; Hua Ren; Yue-Ping Liu; Xiao-Hui He; Mei Dong; Yong-Wen Song; Ye-Xiong Li
Journal:  Ann Hematol       Date:  2016-05-21       Impact factor: 3.673

Review 6.  Non-Hodgkin lymphoma.

Authors:  Kate R Shankland; James O Armitage; Barry W Hancock
Journal:  Lancet       Date:  2012-07-25       Impact factor: 79.321

7.  Orofacial tumours and tumour-like lesions in Ghana: a 6-year prospective study.

Authors:  G E Parkins; G A Armah; Y Tettey
Journal:  Br J Oral Maxillofac Surg       Date:  2008-12-27       Impact factor: 1.651

8.  NHL - Extranodal T-cell lymphoma.

Authors:  Seema Devi; Richi Sinha; Rakesh Kumar Singh; Gagan Mehta
Journal:  Natl J Maxillofac Surg       Date:  2015 Jan-Jun

9.  Malignant lymphomas in the head and neck region--a retrospective, single-center study over 41 years.

Authors:  Christian Walter; Thomas Ziebart; Keyvan Sagheb; Roman Kia Rahimi-Nedjat; Asina Manz; Georg Hess
Journal:  Int J Med Sci       Date:  2015-01-07       Impact factor: 3.738

Review 10.  T-cell lymphomas, a challenging disease: types, treatments, and future.

Authors:  Helen Ma; Maher Abdul-Hay
Journal:  Int J Clin Oncol       Date:  2016-10-14       Impact factor: 3.402

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.